Login
← Go Back
Syngene International
SYNGENE · Pharma > Pharmaceuticals & Drugs · Chairman: Kiran Mazumdar Shaw · MD: Jonathan Hunt · Listing date: Aug. 11, 2015 · Employees: 5437 · Bangalore · http://www.syngeneintl.com
Stock Price vs Company Growth
1d
1.1%
1w
1.2%
1m
6.2%
3m
5.0%
6m
16.0%
1y
40.5%
5y
8.0%
10y
7.1%
all
9.4%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 409 1.1%
398
517
Company Overview
Sales
3,739 Cr
Growth: 2.8%
Profit after Tax
317 Cr
Growth: -10.1%
Mid Cap
16,520 Cr
P/E: 52.1x
Industry P/E: 32.3x
Fundamentals
Sales (Cr) ₹ 3,739
Growth 2.8%
EBITDA 24.6%
P/S 4.4x
Dividend 0.2%
P/E 52.1x
Book Value ₹ 120
PEG Ratio 18.5x
ROE 6.5%
P/B 3.4x
Shareholding Pattern
Institutions
Government Pension Fund Global
1.14 %
Uti-Mid Cap Fund
1.03 %
Qualified Institutional Buyer
0.15 %
Promoters
Biocon Limited
70.1 %
Biocon Limited Employee Welfare Trust (Murali Krishnan K N And Amitava Saha)
0.32 %
Yamini R Mazumdar
0.01 %
Others
Increase    Decrease    No change
Company Profile Detailed
The company is a contract research, development, and manufacturing services company that offers a broad range of scientific services from the earliest stages of discovery to commercial supplies. This positions the Company as an end-to-end service provider within its sector.
Belongs to (30 Indices) view more
Investors (435)
mahesh.g...
ajit.man...
ramakris...
Followers (15)
yogesh
nitin2
keerthi